User login
Dr. Kelly K. Hunt discusses findings that sentinel lymph node (SLN) biopsy when done after --rather than before--neoadjuvant chemotherapy cuts the need for axillary dissections in patients with stage T2-T3 breast tumors . Sherry Boschert of the Global Medical News Network (GMNN) reports from the annual meeting of the American Surgical Association in Indian Wells, Calif.
Dr. Kelly K. Hunt discusses findings that sentinel lymph node (SLN) biopsy when done after --rather than before--neoadjuvant chemotherapy cuts the need for axillary dissections in patients with stage T2-T3 breast tumors . Sherry Boschert of the Global Medical News Network (GMNN) reports from the annual meeting of the American Surgical Association in Indian Wells, Calif.
Dr. Kelly K. Hunt discusses findings that sentinel lymph node (SLN) biopsy when done after --rather than before--neoadjuvant chemotherapy cuts the need for axillary dissections in patients with stage T2-T3 breast tumors . Sherry Boschert of the Global Medical News Network (GMNN) reports from the annual meeting of the American Surgical Association in Indian Wells, Calif.